Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Receptors, Androgen | 6 | 2022 | 1079 | 1.210 |
Why?
|
Small Cell Lung Carcinoma | 3 | 2024 | 423 | 0.360 |
Why?
|
Computational Biology | 2 | 2023 | 3517 | 0.350 |
Why?
|
Gene Expression Regulation, Neoplastic | 10 | 2024 | 8554 | 0.340 |
Why?
|
Prostatic Neoplasms | 5 | 2022 | 11122 | 0.320 |
Why?
|
Chromosomal Proteins, Non-Histone | 4 | 2024 | 727 | 0.310 |
Why?
|
Epigenomics | 5 | 2024 | 943 | 0.290 |
Why?
|
Transcription Factors | 9 | 2024 | 12130 | 0.280 |
Why?
|
Drug Resistance, Neoplasm | 6 | 2024 | 5305 | 0.250 |
Why?
|
Cell Line, Tumor | 14 | 2024 | 16990 | 0.250 |
Why?
|
Workflow | 2 | 2021 | 851 | 0.240 |
Why?
|
Hepatocyte Nuclear Factor 3-alpha | 2 | 2021 | 164 | 0.220 |
Why?
|
Carcinoma, Ductal, Breast | 2 | 2022 | 1085 | 0.220 |
Why?
|
Chromatin | 5 | 2023 | 2961 | 0.220 |
Why?
|
Glycocalyx | 1 | 2024 | 97 | 0.210 |
Why?
|
Breast Neoplasms | 7 | 2024 | 21019 | 0.190 |
Why?
|
Receptors, Fibroblast Growth Factor | 1 | 2021 | 191 | 0.180 |
Why?
|
Genes, myc | 1 | 2022 | 390 | 0.180 |
Why?
|
Inflammatory Breast Neoplasms | 1 | 2023 | 147 | 0.180 |
Why?
|
Cyclic AMP Response Element-Binding Protein A | 1 | 2019 | 21 | 0.170 |
Why?
|
SOXB1 Transcription Factors | 1 | 2021 | 286 | 0.170 |
Why?
|
Adenosine Deaminase | 1 | 2021 | 251 | 0.160 |
Why?
|
Androgen Receptor Antagonists | 1 | 2019 | 125 | 0.160 |
Why?
|
Quinolines | 1 | 2024 | 765 | 0.160 |
Why?
|
Stromal Cells | 1 | 2024 | 1330 | 0.150 |
Why?
|
Cell Transformation, Neoplastic | 3 | 2024 | 2827 | 0.150 |
Why?
|
Phenylurea Compounds | 1 | 2021 | 529 | 0.150 |
Why?
|
Carcinoma, Lobular | 1 | 2022 | 481 | 0.150 |
Why?
|
Lymphoma, Extranodal NK-T-Cell | 1 | 2018 | 48 | 0.150 |
Why?
|
Carcinoma, Neuroendocrine | 1 | 2021 | 339 | 0.140 |
Why?
|
Software | 3 | 2023 | 4434 | 0.140 |
Why?
|
High-Throughput Nucleotide Sequencing | 2 | 2021 | 3639 | 0.140 |
Why?
|
Sequence Analysis, RNA | 3 | 2023 | 2021 | 0.140 |
Why?
|
Prostate | 2 | 2022 | 1773 | 0.140 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2022 | 988 | 0.140 |
Why?
|
Receptor, erbB-2 | 2 | 2024 | 2557 | 0.140 |
Why?
|
Proto-Oncogene Proteins c-mdm2 | 1 | 2018 | 368 | 0.130 |
Why?
|
Lymphoma, T-Cell | 1 | 2018 | 304 | 0.130 |
Why?
|
Enhancer Elements, Genetic | 2 | 2021 | 1363 | 0.120 |
Why?
|
Lung Neoplasms | 3 | 2024 | 13381 | 0.120 |
Why?
|
NF-kappa B | 1 | 2023 | 2490 | 0.120 |
Why?
|
Neuroendocrine Tumors | 1 | 2021 | 641 | 0.120 |
Why?
|
BRCA2 Protein | 1 | 2019 | 805 | 0.120 |
Why?
|
Mutation | 5 | 2024 | 30053 | 0.120 |
Why?
|
Melanoma, Experimental | 1 | 2018 | 561 | 0.120 |
Why?
|
Cytotoxicity, Immunologic | 1 | 2018 | 1351 | 0.110 |
Why?
|
Estrogen Receptor alpha | 1 | 2018 | 583 | 0.110 |
Why?
|
Androgen Antagonists | 1 | 2022 | 1410 | 0.110 |
Why?
|
RNA | 1 | 2023 | 2725 | 0.110 |
Why?
|
Nuclear Proteins | 4 | 2023 | 5799 | 0.110 |
Why?
|
BRCA1 Protein | 1 | 2019 | 1158 | 0.100 |
Why?
|
DNA Copy Number Variations | 1 | 2021 | 2020 | 0.100 |
Why?
|
RNA-Binding Proteins | 1 | 2021 | 1898 | 0.100 |
Why?
|
Tumor Suppressor Protein p53 | 2 | 2021 | 2917 | 0.100 |
Why?
|
Antineoplastic Agents | 5 | 2021 | 13642 | 0.090 |
Why?
|
Testosterone | 1 | 2022 | 2472 | 0.090 |
Why?
|
Esophageal Neoplasms | 1 | 2021 | 1654 | 0.090 |
Why?
|
T-Lymphocytes, Cytotoxic | 1 | 2018 | 1784 | 0.090 |
Why?
|
Models, Genetic | 1 | 2020 | 3442 | 0.090 |
Why?
|
Sequence Analysis, DNA | 1 | 2021 | 4740 | 0.090 |
Why?
|
RNA, Double-Stranded | 2 | 2021 | 294 | 0.080 |
Why?
|
Cell Lineage | 1 | 2018 | 2557 | 0.080 |
Why?
|
Pyrimidines | 1 | 2021 | 3028 | 0.080 |
Why?
|
Single-Cell Analysis | 1 | 2020 | 2451 | 0.080 |
Why?
|
Humans | 29 | 2024 | 761596 | 0.080 |
Why?
|
Mice | 10 | 2024 | 81539 | 0.070 |
Why?
|
Phenylthiohydantoin | 2 | 2019 | 205 | 0.070 |
Why?
|
Interferons | 2 | 2021 | 706 | 0.070 |
Why?
|
Alleles | 1 | 2018 | 6864 | 0.070 |
Why?
|
Peptides | 1 | 2018 | 4358 | 0.070 |
Why?
|
Proto-Oncogene Proteins | 1 | 2018 | 4514 | 0.060 |
Why?
|
Paclitaxel | 2 | 2023 | 1732 | 0.060 |
Why?
|
Animals | 12 | 2024 | 168475 | 0.060 |
Why?
|
Proteins | 1 | 2020 | 6032 | 0.060 |
Why?
|
Epigenesis, Genetic | 3 | 2024 | 3801 | 0.060 |
Why?
|
Transcription, Genetic | 1 | 2018 | 7593 | 0.060 |
Why?
|
Neoplasms | 2 | 2023 | 22173 | 0.060 |
Why?
|
DNA-Binding Proteins | 2 | 2018 | 9610 | 0.060 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2022 | 9280 | 0.060 |
Why?
|
Nitriles | 2 | 2019 | 971 | 0.060 |
Why?
|
Signal Transduction | 6 | 2024 | 23447 | 0.060 |
Why?
|
Octamer Transcription Factor-3 | 1 | 2024 | 223 | 0.050 |
Why?
|
Adenocarcinoma | 1 | 2021 | 6345 | 0.050 |
Why?
|
Benzamides | 2 | 2019 | 1371 | 0.050 |
Why?
|
Protein Binding | 3 | 2021 | 9353 | 0.050 |
Why?
|
Brain Neoplasms | 1 | 2024 | 9032 | 0.050 |
Why?
|
Male | 9 | 2024 | 360846 | 0.050 |
Why?
|
Gene Expression Regulation | 1 | 2020 | 11904 | 0.050 |
Why?
|
Xenograft Model Antitumor Assays | 2 | 2021 | 3605 | 0.050 |
Why?
|
Histone Demethylases | 1 | 2023 | 323 | 0.040 |
Why?
|
Coculture Techniques | 1 | 2024 | 1341 | 0.040 |
Why?
|
HEK293 Cells | 2 | 2020 | 4281 | 0.040 |
Why?
|
Endogenous Retroviruses | 1 | 2021 | 111 | 0.040 |
Why?
|
Mucin-1 | 1 | 2024 | 540 | 0.040 |
Why?
|
T Cell Transcription Factor 1 | 1 | 2019 | 72 | 0.040 |
Why?
|
Tumor Microenvironment | 2 | 2023 | 3878 | 0.040 |
Why?
|
3' Untranslated Regions | 1 | 2021 | 519 | 0.040 |
Why?
|
Imidazolines | 1 | 2018 | 18 | 0.040 |
Why?
|
Base Sequence | 2 | 2021 | 12441 | 0.040 |
Why?
|
STAT3 Transcription Factor | 1 | 2023 | 871 | 0.040 |
Why?
|
Cell Survival | 2 | 2018 | 5791 | 0.040 |
Why?
|
Introns | 1 | 2021 | 981 | 0.040 |
Why?
|
Kruppel-Like Transcription Factors | 1 | 2021 | 504 | 0.040 |
Why?
|
Skin Neoplasms | 1 | 2018 | 5821 | 0.040 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2023 | 1136 | 0.040 |
Why?
|
Azepines | 1 | 2020 | 329 | 0.040 |
Why?
|
HMGB Proteins | 1 | 2018 | 45 | 0.040 |
Why?
|
Mi-2 Nucleosome Remodeling and Deacetylase Complex | 1 | 2018 | 113 | 0.040 |
Why?
|
Tamoxifen | 1 | 2022 | 965 | 0.040 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2021 | 698 | 0.040 |
Why?
|
Antigen Presentation | 1 | 2023 | 1251 | 0.040 |
Why?
|
Depsipeptides | 1 | 2018 | 95 | 0.040 |
Why?
|
Cell Cycle Proteins | 2 | 2020 | 3449 | 0.040 |
Why?
|
Mitochondrial Proteins | 1 | 2023 | 976 | 0.040 |
Why?
|
Drug Synergism | 1 | 2021 | 1757 | 0.040 |
Why?
|
DNA Methylation | 2 | 2024 | 4399 | 0.040 |
Why?
|
Chromatin Assembly and Disassembly | 1 | 2021 | 634 | 0.040 |
Why?
|
Cell Communication | 1 | 2024 | 1657 | 0.030 |
Why?
|
Ikaros Transcription Factor | 1 | 2018 | 232 | 0.030 |
Why?
|
Regulatory Sequences, Nucleic Acid | 1 | 2020 | 790 | 0.030 |
Why?
|
Female | 10 | 2024 | 392705 | 0.030 |
Why?
|
Open Reading Frames | 1 | 2019 | 815 | 0.030 |
Why?
|
Cell Proliferation | 2 | 2024 | 10451 | 0.030 |
Why?
|
DNA Helicases | 1 | 2021 | 851 | 0.030 |
Why?
|
Mice, Inbred NOD | 1 | 2020 | 1827 | 0.030 |
Why?
|
Acetylation | 1 | 2018 | 1055 | 0.030 |
Why?
|
Amino Acids | 1 | 2021 | 1718 | 0.030 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 1 | 2021 | 1136 | 0.030 |
Why?
|
Immunotherapy | 2 | 2023 | 4652 | 0.030 |
Why?
|
Multiprotein Complexes | 1 | 2021 | 1120 | 0.030 |
Why?
|
Fluorescent Antibody Technique | 1 | 2019 | 2467 | 0.030 |
Why?
|
Endonucleases | 1 | 2018 | 371 | 0.030 |
Why?
|
Gene Expression Profiling | 2 | 2023 | 9420 | 0.030 |
Why?
|
Janus Kinase 2 | 1 | 2018 | 560 | 0.030 |
Why?
|
Organoids | 1 | 2021 | 746 | 0.030 |
Why?
|
Triazoles | 1 | 2020 | 903 | 0.030 |
Why?
|
Receptors, Estrogen | 1 | 2022 | 2209 | 0.030 |
Why?
|
Homeodomain Proteins | 1 | 2023 | 2418 | 0.030 |
Why?
|
Sequence Alignment | 1 | 2018 | 2180 | 0.030 |
Why?
|
Disease Progression | 2 | 2021 | 13510 | 0.030 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2023 | 2872 | 0.030 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2018 | 1334 | 0.030 |
Why?
|
Bone Marrow Cells | 1 | 2020 | 2417 | 0.030 |
Why?
|
RNA Interference | 1 | 2021 | 2832 | 0.030 |
Why?
|
Remission Induction | 1 | 2018 | 2397 | 0.030 |
Why?
|
Germ-Line Mutation | 1 | 2019 | 1858 | 0.020 |
Why?
|
Cluster Analysis | 1 | 2018 | 2707 | 0.020 |
Why?
|
Down-Regulation | 1 | 2018 | 2919 | 0.020 |
Why?
|
Molecular Targeted Therapy | 1 | 2021 | 2811 | 0.020 |
Why?
|
Stem Cells | 1 | 2023 | 3524 | 0.020 |
Why?
|
Antineoplastic Agents, Hormonal | 1 | 2018 | 1520 | 0.020 |
Why?
|
RNA, Small Interfering | 1 | 2018 | 3430 | 0.020 |
Why?
|
Interferon-gamma | 1 | 2018 | 3162 | 0.020 |
Why?
|
Tumor Suppressor Proteins | 1 | 2019 | 2805 | 0.020 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2020 | 1640 | 0.020 |
Why?
|
Up-Regulation | 1 | 2018 | 4125 | 0.020 |
Why?
|
Promoter Regions, Genetic | 1 | 2019 | 5790 | 0.020 |
Why?
|
Genome, Human | 1 | 2021 | 4425 | 0.020 |
Why?
|
Histones | 1 | 2018 | 2580 | 0.020 |
Why?
|
Genomics | 1 | 2023 | 5821 | 0.020 |
Why?
|
Repressor Proteins | 1 | 2018 | 2986 | 0.020 |
Why?
|
Neoplasm Metastasis | 1 | 2018 | 4915 | 0.020 |
Why?
|
Apoptosis | 1 | 2023 | 9490 | 0.020 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2021 | 4580 | 0.020 |
Why?
|
Cell Line | 1 | 2020 | 15601 | 0.020 |
Why?
|
Immunohistochemistry | 1 | 2019 | 11076 | 0.020 |
Why?
|
Mice, Transgenic | 1 | 2018 | 9542 | 0.020 |
Why?
|
Genetic Testing | 1 | 2018 | 3537 | 0.010 |
Why?
|
Bacterial Proteins | 1 | 2018 | 3847 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2018 | 12794 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2020 | 22176 | 0.010 |
Why?
|
Prognosis | 1 | 2022 | 29629 | 0.010 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2021 | 11742 | 0.010 |
Why?
|
Aged | 1 | 2018 | 169310 | 0.000 |
Why?
|
Middle Aged | 1 | 2018 | 220921 | 0.000 |
Why?
|
Adult | 1 | 2018 | 221210 | 0.000 |
Why?
|